Chen R F, Lee C Y. Adenoviruses types cell receptors and local innate cytokines in adenovirus infection [J]. Int Rev Immunol, 2014, 33(1): 45-53.
[2]
Rowe W P. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture [J]. Proc Soc Exp Biol Med, 1953, 84(3): 570-573.
[3]
Hilleman M R, Werner J H. Recovery of new agent from patients with acute respiratory illness[J]. Proc Soc Exp Biol Med, 1954, 85(1):183-188.
[4]
Xu L, Liu J, Liu C, et al. Case-control study of the epidemiological and clinical features of human adenovirus 55 and human adenovirus 7 infection in children with acute lower respiratory tract infections in Beijing, China, 2008-2013[J]. BMC Infect Dis, 2018, 18(1):634.
[5]
Zhu Z, Zhang Y, Xu S, et al. Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11[J]. J Clin Microbiol, 2009, 47(3):697-703.
[6]
Xie L, Bing Z, Zhou J, et al. Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia [J]. Virology, 2018,15(1):123.
[7]
Qu J X, Gu L, Pu Z H, et al. Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity [J]. BMC Infect Dis, 2015, 15: 89.
[8]
Lion, T. Adenovirus infections in immunocompetent and immunocompromised patients [J]. Clin Microbiol Rev, 2014, 27(3): 441-462.
[9]
Cederwall S, Pahlman L I. Respiratory adenovirus infections in immunocompetent and immuno- compromised adult patients[J]. Epidemiol Infect,2020,147:e328.
[10]
Cao B, Huang G H, Pu Z H, et al. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia[J]. Chest, 2014, 145(1): 79-86.
Padin D S, Faix D, Brodine S, et al. Retrospective analysis of demographic and clinical factors associated with etiology of febrile respiratory illness among US military basic trainees[J]. BMC Infect Dis, 2014, 14:576.
[15]
Yao L H, Wang C, Wei T L, et al. Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017-2018[J]. Virol,2019,16(1):78.
[16]
Lai C Y, Lee C J, Lu C Y, et al. Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010-2011[J].PLoS One, 2013, 8(1):e53614.
[17]
Huang Y C , Huang S L, Chen S P, et al. Adenovirus infection associated with central nervous system dysfunction in children [J]. J Clin Virol, 2013, 57(4): 300-304.
Sandkovsky U, Vargas L, Florescu D F. Adenovirus:current epidemiology and emerging approaches to prevention and treatment[J]. Curr Infect Dis Rep, 2014, 16(8): 416.
[20]
Fu Y X, Tang, Z Z, Ye Z X, et al. Human adenovirus type 7 infection causes a more severe disease than type 3 [J]. BMC Infect Dis, 2019, 19(1): 36.
[21]
Usman N, Suarez M. Adenoviruses, in StatPearls. 2021: Treasure Island (FL).
[22]
Cheng C C, Huang L M, Kao C L, et al. Molecular and clinical characteristics of adenoviral infections in Taiwanese children in 2004-2005 [J]. Eur J Pediatr, 2008, 167(6): 633-640.
[23]
Lenaerts L, De Clercq E, Naesens L, et al. Clinical features and treatment of adenovirus infections [J]. Rev Med Virol, 2008, 18(6): 357-374.
[24]
Park J Y, Kim B J, Kim B J, et al. Clinical features and courses of adenovirus pneumonia in healthy young adults during an outbreak among Korean military personnel [J]. PLoS One, 2017, 12(1): e0170592.
[25]
Kawasaki Y, Kawasaki Y, Kawasaki Y, et al. Correlation between serum interleukin 6 and C-reactive protein concentrations in patients with adenoviral respiratory infection [J]. Pediatr Infect Dis, 2002, 21(5): 370-374.
[26]
Fernández J A, Tapia L, Palomino M A, et al.Plasma interferon-gamma, interleukin-10 and soluble markers of immune activation in infants with primary adenovirus (ADV) and respiratory syncytial virus (RSV) infection[J]. Eur Cytokine Netw, 2005, 16(1):35-40.
[27]
Dai H, Xi H, Huang L, et al. Molecular epidemiology and clinical features analysis of respiratory adenovirus infections reveals correlations between genotype, inflammatory biomarkers, and disease severity [J]. Biomed Res Int, 2020, 2020: 4357910.
[28]
Chen Q, Liu J, Liang W, et al. Clinical features, replication competence, and innate immune responses of human adenovirus type 7 infection [J]. J Infect Dis, 2021, 223(8):1390-1399.
[29]
Yu Z, Zeng Z, Zhang J, et al. Fatal Community-acquired Pneumonia in children caused by re-emergent human adenovirus 7d associated with higher severity of illness and fatality rate [J]. Sci Rep, 2016, 6: 37216.
[30]
Bhatti Z, Dhamoon A. Fatal adenovirus infection in an immunocompetent host [J]. Am J Emerg Med, 2017, 35(7): 1034 e1-1034 e2.
[31]
Sun B, He H, Wang Z, et al. Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study [J]. Crit Care, 2014, 18(4): 456.
[32]
Huang H,Chen Y,Ma L Y,et al. Analysis of clinical characteristics and risk factors of severe adenovirus pneumonia in children [J]. Front Pediatr, 2021, 9: 566797.
[33]
Hendrickx R, Stichling N, Koelen J, et al. Innate immunity to adenovirus [J]. Hum Gene Ther, 2014, 25(4): 265-284.
[34]
Pettengill M A, Haren S D, Li N, et al. Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naive B cells [J]. Innate Immun, 2016, 22(6): 433-443.
[35]
Sun J, Xiao Y, Zhang M, et al. Serum inflammatory markers in patients with adenovirus respiratory infection[J]. Med Sci Monit, 2018, 24:3848-3855.
Lim J U, Choi J Y, Jeong H J, et al. Comparison of clinical characteristics and inflammatory cytokines between hypoxemic and non-hypoxemic human adenovirus 55 pneumonia [J]. J Thorac Dis, 2020, 12(8): 4044-4056.
2022, Vol. 33 
